RHHBY
Price
$34.89
Change
+$0.39 (+1.13%)
Updated
Dec 23 closing price
37 days until earnings call
SNPHY
Price
$9.68
Change
-$0.20 (-2.02%)
Updated
Dec 23 closing price
Ad is loading...

RHHBY vs SNPHY

Header iconRHHBY vs SNPHY Comparison
Open Charts RHHBY vs SNPHYBanner chart's image
Roche Holding
Price$34.89
Change+$0.39 (+1.13%)
Volume$1.59M
CapitalizationN/A
Santen Pharmaceutical
Price$9.68
Change-$0.20 (-2.02%)
Volume$13.97K
CapitalizationN/A
RHHBY vs SNPHY Comparison Chart
Loading...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHBY vs. SNPHY commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHBY is a StrongBuy and SNPHY is a Sell.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (RHHBY: $34.96 vs. SNPHY: $10.93)
Brand notoriety: RHHBY and SNPHY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHBY: 47% vs. SNPHY: 4%
Market capitalization -- RHHBY: $250.69B vs. SNPHY: $3.26B
RHHBY [@Pharmaceuticals: Major] is valued at $250.69B. SNPHY’s [@Pharmaceuticals: Major] market capitalization is $3.26B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHBY’s FA Score shows that 1 FA rating(s) are green whileSNPHY’s FA Score has 1 green FA rating(s).

  • RHHBY’s FA Score: 1 green, 4 red.
  • SNPHY’s FA Score: 1 green, 4 red.
According to our system of comparison, both RHHBY and SNPHY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHBY’s TA Score shows that 4 TA indicator(s) are bullish while SNPHY’s TA Score has 2 bullish TA indicator(s).

  • RHHBY’s TA Score: 4 bullish, 4 bearish.
  • SNPHY’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, RHHBY is a better buy in the short-term than SNPHY.

Price Growth

RHHBY (@Pharmaceuticals: Major) experienced а -2.46% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was +6.74% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.40%. For the same industry, the average monthly price growth was -2.78%, and the average quarterly price growth was -2.25%.

Reported Earning Dates

RHHBY is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.40% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($251B) has a higher market cap than SNPHY($3.26B). RHHBY has higher P/E ratio than SNPHY: RHHBY (19.46) vs SNPHY (15.60). RHHBY YTD gains are higher at: 0.255 vs. SNPHY (-0.649). RHHBY has higher annual earnings (EBITDA): 19.1B vs. SNPHY (17.2B). SNPHY has more cash in the bank: 62.3B vs. RHHBY (7.51B). RHHBY has less debt than SNPHY: RHHBY (25.4B) vs SNPHY (40.1B). SNPHY has higher revenues than RHHBY: SNPHY (270B) vs RHHBY (60B).
RHHBYSNPHYRHHBY / SNPHY
Capitalization251B3.26B7,690%
EBITDA19.1B17.2B111%
Gain YTD0.255-0.649-39%
P/E Ratio19.4615.60125%
Revenue60B270B22%
Total Cash7.51B62.3B12%
Total Debt25.4B40.1B63%
FUNDAMENTALS RATINGS
RHHBY vs SNPHY: Fundamental Ratings
RHHBY
SNPHY
OUTLOOK RATING
1..100
1084
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
24
Undervalued
PROFIT vs RISK RATING
1..100
85100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5960
P/E GROWTH RATING
1..100
3650
SEASONALITY SCORE
1..100
4550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (13) in the null industry is in the same range as SNPHY (24). This means that RHHBY’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBY's Profit vs Risk Rating (85) in the null industry is in the same range as SNPHY (100). This means that RHHBY’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBY's SMR Rating (99) in the null industry is in the same range as SNPHY (100). This means that RHHBY’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBY's Price Growth Rating (59) in the null industry is in the same range as SNPHY (60). This means that RHHBY’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBY's P/E Growth Rating (36) in the null industry is in the same range as SNPHY (50). This means that RHHBY’s stock grew similarly to SNPHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHBYSNPHY
RSI
ODDS (%)
Bullish Trend 2 days ago
60%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 22 days ago
54%
Declines
ODDS (%)
Bearish Trend 6 days ago
45%
Bearish Trend 6 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
41%
Bearish Trend 2 days ago
69%
View a ticker or compare two or three
Ad is loading...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWAUX15.410.16
+1.05%
Nationwide GQG US Quality Eq A
VGPMX13.010.12
+0.93%
Vanguard Global Capital Cycles Investor
SBHIX22.830.15
+0.66%
Saratoga Health & Biotechnology I
FKUTX22.530.09
+0.40%
Franklin Utilities A1
DGEZX12.14N/A
N/A
Destinations Equity Income Z

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
+1.13%
RHHVF - RHHBY
65%
Loosely correlated
+0.08%
NVS - RHHBY
37%
Loosely correlated
+1.38%
JNJ - RHHBY
37%
Loosely correlated
+0.55%
RHHBF - RHHBY
32%
Poorly correlated
+6.60%
BMY - RHHBY
28%
Poorly correlated
+0.44%
More

SNPHY and

Correlation & Price change

A.I.dvisor tells us that SNPHY and RHHBF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and RHHBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
-2.02%
RHHBF - SNPHY
9%
Poorly correlated
+6.60%
RHHVF - SNPHY
9%
Poorly correlated
+0.08%
RHHBY - SNPHY
6%
Poorly correlated
+1.13%
OTSKY - SNPHY
3%
Poorly correlated
+0.96%
SNPHF - SNPHY
1%
Poorly correlated
N/A
More